Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Shrinking Workforce, Increasing Demand Pose Imminent Challenges in Rheumatology
-
- Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis Carry Similar Disease Burden
- Minority of Inflammatory Back Pain Cases Progress to Spondyloarthritis
- Tamper-resistant Formulations of Higher-strength Oxycodone Decrease Use
- Trump’s ‘New Plan’ to Combat Opioid Crisis Draws Criticism, Optimism
- Long-term Benlysta Treatment Safe, Efficacious for Lupus
- RNA Blood Test for Fibromyalgia Available
- Switching from Humira to Biosimilar Cyltezo Safe, Effective in RA
- Giant Cell Arteritis: A Call for Interprofessional Education and Collaboration Leonard H. Calabrese, DO
-
- Giant Cell Arteritis: Overcoming the Limitations of Conventional Agents With Biologic Therapy
- Diagnosis Detective: Deciphering Dermatologic Symptoms of Rheumatic Diseases
- CV Mortality Risk Threefold Higher Among Younger Patients With RA
- Fewer Women Than Men Respond to TNF Inhibitors in Ankylosing Spondylitis
- Inflammatory Arthritis Disease Activity Improved in New Millennium
- Physical Activity Low Among Older Adults With, Without Knee OA
- ACR Calls on Department of Labor to Protect Essential Health Benefits
- ACR, Physician Groups Warn HHS Against New Pricing Proposals for Biologics
-
- Biosimilar Competition in U.S. Limited by Accumulative Regulatory Failures
- Gottlieb Denounces ‘Rigged’ Rebate System Restricting Biosimilar Access